Health care utilization in patients with migraine: Demographics and patterns of care in the ambulatory setting

Headache

Volumn 43, Issue 4, 2003, Pages 330-335

  Gibbs, Trevor S ^a   Fleischer Jr , Alan B ^a   Feldman, Steven R ^a   Sam, Maria C ^a   O'Donovan, Cormac A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Headache; Health services research; Triptan

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; AMITRIPTYLINE; BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; BUTORPHANOL TARTRATE; CAFERGOT; CAFFEINE; DEXTROPROPOXYPHENE NAPSILATE; HYDROXYZINE EMBONATE; ISOMETHEPTENE MUCATE; PARACETAMOL; PROMETHAZINE; PROPRANOLOL; SUMATRIPTAN;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CHILD; DEMOGRAPHY; DRUG EFFICACY; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; INFANT; MALE; MIGRAINE; OUTPATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OFFICE VISITS; PREVALENCE; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 0037387243     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03067.x     Document Type: Article

References (16)

1. Anonymous. Prevalence of chronic migraine headaches - United States, 1980-1989. MMWR Morb Mortal Wkly Rep. 1991;40:331, 337-338.
2. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638-645.
3. Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol. 1994;34(suppl 2):6-11.
4. Osterhaus JT, Gutterman DI, Plachetka JR. Healthcare resources and lost labor costs of migraine headache in U.S. Pharmacoeconomics. 1992; 2:67-76.
5. Fishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia. 1999;19:50-57.
6. Rasmussen BK. Epidemiology and socio-economic impact of headache. Cephalalgia. 1999;19(suppl 25): 20-23.
7. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58:885-894.
8. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996;16: 231-238.
9. Stewart WF, Lipton RB, Celentano DD, Michael ML. Prevalence of migraine headache in the United States: relation to age, income, race, and other socio-demographic factors. JAMA. 1992;267:64-69.
10. Winner P. Pediatric headaches: what's new? Curr Opin Neurol. 1999;12:269-272.
11. Stang PE, Yanagihara PA, Swanson JW, et al. Incidence of migraine headache: a population-based study in Olmsted County, Minnesota. Neurology. 1992;42:1657-1662.
12. Hu XH, O'Donnell F, Kunkel RS, Gerard G, Markson LE, Berger ML. Survey of migraineurs referred to headache specialist: care, satisfaction, and outcomes. Neurology. 2000;55:141-143.
13. Limmroth V, Diener HC. New anti-migraine drugs: present and beyond the millennium. Int J Clin Pract. 1998;52:566-570.
14. Diener HC, Limmroth V. Acute management of migraine: triptans and beyond. Curr Opin Neurol. 1999; 12:261-267.
15. Lofland JH, Kim SS, Batenhorst AS, et al. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clin Proc. 2001;76: 1093-1101.
16. Krobot KJ, Schroder-Bernhardi D, Pfaffenrath V. Migraine consultation patterns in primary care. Results from the PCAOM study 1994-1996. Cephalalgia. 1999;19:831-840.